ASCO Sarcoma | Conference

Kelly Morgan, MS, CGC, on Improving Family Discussions on Genetic Risk for Cancer
August 14, 2020

The MSK expert explained that pre- and post-test education on genetic testing also improved family discussions about their risk.

Anlotinib Offers Efficacy Across Subtypes of Soft-Tissue Sarcoma
June 13, 2016

A phase II trial showed that the tyrosine kinase inhibitor anlotinib has promising efficacy across a variety of subtypes of advanced refractory soft-tissue sarcoma.

Gemcitabine Plus Pazopanib Shows Promise in Soft-Tissue Sarcomas
June 07, 2016

Combined therapy with gemcitabine and pazopanib appears to be a viable treatment option for patients with soft-tissue sarcomas refractory to anthracycline or ifosfamide.